DrugPatentWatch Database Preview

Amring Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AMRING PHARMS, and what generic and branded alternatives to AMRING PHARMS drugs are available?

AMRING PHARMS has six approved drugs.

Summary for Amring Pharms

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	6

Drugs and US Patents for Amring Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amring Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	065216-001	Oct 31, 2005	AT	RX	No	No
Amring Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	065219-001	May 1, 2006	AT	RX	No	No
Amring Pharms	BROMFENAC SODIUM	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	202030-001	Jan 9, 2013		DISCN	No	No
Amring Pharms	LATANOPROST	latanoprost	SOLUTION/DROPS;OPHTHALMIC	200925-001	Mar 22, 2011	AT	RX	No	No
Amring Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN	gramicidin; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	065187-001	Oct 28, 2005	AT	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Amring Pharms